(January 8, 2024, 2:39 PM EST) -- AMARILLO, Texas — The three states that moved to intervene in a lawsuit challenging the U.S. Food and Drug Administration’s approval of mifepristone and misoprostol say the arguments that intervention should be denied “rest on a string of dubious speculations and the strange assertion that it would be more convenient to the Federal Government to litigate in multiple forums.”...